Hyperaldosteronism screening: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
Line 9: | Line 9: | ||
==Screening== | ==Screening== | ||
==References== | ==References== |
Latest revision as of 13:59, 25 July 2016
Hyperaldosteronism Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor-in-Chief: Soumya Sachdeva
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Screening for hyperaldosteronism is done by measuring the aldosterone-renin ratio(ARR) on current blood pressure medication (stop spironolactone for 4 weeks) and with hypokalemia corrected (ARR screen positive if ARR>750 pmol/l:ng/ml/h and aldosterone>450 pmol/l)[1]
Screening
References
- ↑ Harrison's Principles of Internal Medicine